Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-08

Clinical Trial Update: Lutonix Global SFA Registry

View source ↗

Summary

A completed update for the Lutonix Global SFA Registry evaluating a peripheral artery disease indication. No detailed results are provided in the update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lutonix (paclitaxel-coated balloon catheter)

Snippet

Sponsor: C. R. Bard | Conditions: Peripheral Artery Disease | Status: COMPLETED